Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 3, 2010, Pages 325-331

  Marin, Jose M ^a,b   Soriano, Joan B ^b,c   Carrizo, Santiago J ^a   Boldova, Ana ^a   Celli, Bartolome R ^d  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Fundacion Caubet CIMERA Illes Balears   (Spain)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic obstructive pulmonary disease; Cohort studies; Hospitalization; Obstructive sleep apnea

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE EXACERBATION; FOLLOW UP; GENDER; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SMOKING; STROKE; TREATMENT OUTCOME; AGE; FEMALE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY;

AGE FACTORS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 77956267083     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200912-1869OC     Document Type: Article

References (33)

1. Jemal A,Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-1259.
2. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-1689.
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;323:1230-1235.
4. Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med 1985;6:51-61.
5. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am Rev Respir Dis 1995;151:82-86.
6. Shepard JW, Garrison MW, Grither DA, Evans R, Schweitzer PK. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med 1985;78:28-34.
7. Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Oswald M, Kurtz D. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345-349.
8. Bradley TD, Rutherford A, Grossmann RF, Lue F, Zamel N, Moldofsky H, Phillipson EA. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131:835-839.
9. Chaouat A, Weitzenblum E, Krieger J, Sforza E, Hammad H, Oswald M, Kessler R. Prognostic value of lung function and pulmonary haemodynamics in OSA patients trested with CPAP. Eur Respir J 1999;13:1091-1096. (Pubitemid 29288934)
10. Marin JM, Carrizo SJ, Vincente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053.
11. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
12. Marin JM, DeAndres R, Alonso J, Sanchez A, Carrizo S. Long term mortality in the overlap syndrome. Eur Respir J 2008;32:865.
13. Montserrat JM, Amilibia J, Barbe F, Capote F, Duran J, Mangado NG, Jimenez A, Marin JM, Masa F, Teran J. Tratamiento del sindrome de las apneas-hipopneas durante el sueño. Arch Bronconeumol 1998;34:204-206. (Pubitemid 128536974)
14. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30-36. (Pubitemid 23027228)
15. Charlson M, Szatrowsky T, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
16. American Thoracic Society. Lung function testing; selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
17. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 2009;180:692-700.
18. Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003;167:7-14.
19. Ashutosh K, Mead G, Dunsky M. Early effects of oxygen administration and prognosis in chronic pulmonary disease and cor pulmonale. Am Rev Respir Dis 1983;127:399-404. (Pubitemid 13083736)
20. Fletcher EC, Schaal JM, Miller J, Fletcher JG. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 1987;135:525-533. (Pubitemid 17041577)
21. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEnriery CM, Donaldson K, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008;63:306-311.
22. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610.
23. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004;59:574-580. (Pubitemid 38901515)
24. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134. (Pubitemid 36297204)
25. Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC study. Atheroesclrosis 2005;180:367-373.
26. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:613-618. (Pubitemid 41232973)
27. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
28. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-178. (Pubitemid 46092013)
29. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041. (Pubitemid 41609096)
30. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto J, Stubbs R, Hla KM. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31:1071-1078.
31. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, Donner CF, Ambrosino N. The Italian multicenter study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002;20:529-538.
32. Ozsancak A, D'Ambrosio C, Hill NS. Nocturnal noninvasive ventilation. Chest 2008;133:1275-1286.
33. Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication Adherence and persistence in severe obstructive sleep apnea. Sleep 2009;32:623-628.